Neuropeptides in the sympathetic system: presence, plasticity, modulation, and implications

Area of Science:

• Neuroscience
• Autonomic Nervous System Research
• Peptide Signaling

Background:

• Neuropeptides are widely distributed throughout the sympathetic nervous system.
• They modulate neurotransmission at multiple levels, including the central nervous system, ganglia, and target organs.
• Specific neuropeptides like Neuropeptide Y and vasoactive intestinal polypeptide are colocalized with classical neurotransmitters in distinct sympathetic neuron populations.

Purpose of the Study:

• To review the role of neuropeptides in sympathetic nervous system function.
• To explore the plasticity of neuropeptide expression during neuronal development and under physiological/pathological conditions.
• To discuss the clinical implications of neuropeptides in the sympathetic system.

Main Methods:

• Literature review and synthesis of existing research on neuropeptides in the sympathetic nervous system.
• Analysis of neuropeptide co-localization with neurotransmitters (norepinephrine, acetylcholine).
• Examination of neuropeptide expression changes during development, denervation, and in disease states.

Main Results:

• Neuropeptides modulate sympathetic preganglionic neuron excitability and transmission in ganglia.
• Neuropeptide Y (NPY) is found in vasoconstrictor neurons, while vasoactive intestinal polypeptide (VIP) is in sudomotor neurons.
• Neuropeptide expression is dynamic, changing with neuronal phenotype shifts, preganglionic input, and following denervation.
• NPY affects vascular tone and norepinephrine release/action; plasma NPY levels rise during sympathoexcitation and hypertension.
• Abnormal NPY-containing neurites are observed in sympathetic ganglia in aging, diabetes, and dysautonomia.

Conclusions:

• Sympathetic neuropeptides play critical roles in regulating cardiovascular function, neurotransmission, and neuronal plasticity.
• Alterations in neuropeptide expression and localization are associated with significant clinical conditions, including hypertension, diabetes, and autonomic dysfunction.
• Further research into sympathetic neuropeptides is warranted due to their substantial clinical implications.